Questions and answers on the amended Act on Pharmaceuticals - pharmacovigilance

The amended Act on Pharmaceuticals came into effect on 2 April 2013. We would like to summarize the major changes concerning marketing authorisations, pharmacovigilance and clinical trials, in the form of questions and answers.  

 

For detailed information, please contact the employees of the Pharmacovigilance Dept.


Questions and answers relevant to marketing authorisations and clinical trials are available from the respective sections.